AC Immune (ACIU) Non-Current Assets (2015 - 2026)

AC Immune (ACIU) has 12 years of Non-Current Assets data on file, last reported at $73.3 billion in Q1 2026.

• On a quarterly basis, Non-Current Assets rose 111635.33% year-over-year to $73.3 billion in Q1 2026; TTM through Mar 2026 was -$47.4 billion, a 18252.19% decrease from a year earlier, with the FY2025 full-year figure at -$116.5 billion, down 173275.36% from the prior year.
• Non-Current Assets for Q1 2026 stood at $73.3 billion, up from -$120.8 billion in the prior quarter.
• Over the last five years, Non-Current Assets for ACIU reached as high as $73.3 billion in Q1 2026 and fell as low as -$191.7 billion in Q1 2022.
• Historically, Non-Current Assets has averaged -$32.0 billion across 5 years, with a median of $63.5 million in 2023.
• Across the five-year window, Non-Current Assets plunged 234740.01% in 2023 and surged 111635.33% in 2026, its largest moves.
• Year by year, Non-Current Assets stood at $60.0 million in 2022, then plunged by 234740.01% to -$140.9 billion in 2023, then surged by 100.05% to $67.3 million in 2024, then tumbled by 179742.36% to -$120.8 billion in 2025, then soared by 160.63% to $73.3 billion in 2026.
• Per Business Quant data, the three most recent Non-Current Assets figures were $73.3 billion in Q1 2026, -$120.8 billion in Q4 2025, and $72.3 million in Q3 2025.